Prospective observational study to explore genes and proteins predicting efficacy and safety of brigatinib for ALK-gene rearranged non-small-cell lung cancer: study protocol for ABRAID study (WJOG11919L).
Yuichi OzawaYasuhiro KohTetsunari HaseKenji ChibanaKyoichi KairaKyoichi OkishioEiki IchiharaShuji MurakamiMototsugu ShimokawaNobuyuki YamamotoPublished in: Therapeutic advances in medical oncology (2024)
UMIN000042439.